Structure

Physi-Chem Properties

Molecular Weight:  400.33
Volume:  453.63
LogP:  5.32
LogD:  3.989
LogS:  -5.501
# Rotatable Bonds:  1
TPSA:  37.3
# H-Bond Aceptor:  2
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.497
Synthetic Accessibility Score:  5.35
Fsp3:  0.889
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.952
MDCK Permeability:  1.305368550674757e-05
Pgp-inhibitor:  0.075
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.017
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.902

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.214
Plasma Protein Binding (PPB):  93.23954010009766%
Volume Distribution (VD):  1.069
Pgp-substrate:  7.291891574859619%

ADMET: Metabolism

CYP1A2-inhibitor:  0.024
CYP1A2-substrate:  0.679
CYP2C19-inhibitor:  0.174
CYP2C19-substrate:  0.955
CYP2C9-inhibitor:  0.238
CYP2C9-substrate:  0.226
CYP2D6-inhibitor:  0.031
CYP2D6-substrate:  0.044
CYP3A4-inhibitor:  0.882
CYP3A4-substrate:  0.917

ADMET: Excretion

Clearance (CL):  5.99
Half-life (T1/2):  0.091

ADMET: Toxicity

hERG Blockers:  0.157
Human Hepatotoxicity (H-HT):  0.724
Drug-inuced Liver Injury (DILI):  0.022
AMES Toxicity:  0.044
Rat Oral Acute Toxicity:  0.041
Maximum Recommended Daily Dose:  0.901
Skin Sensitization:  0.962
Carcinogencity:  0.88
Eye Corrosion:  0.962
Eye Irritation:  0.87
Respiratory Toxicity:  0.932

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474925

Natural Product ID:  NPC474925
Common Name*:   12-Deacetylhyrtial
IUPAC Name:   (4aS,4bR,6aS,10aS,10bR,12R,12aR)-12-hydroxy-4a,4b,6a,7,7,10a,10b,12a-octamethyl-4,5,6,8,9,10,11,12-octahydro-1H-chrysene-2-carbaldehyde
Synonyms:   12-Deacetylhyrtial
Standard InCHIKey:  DXWFDFCYGZYCCS-XMBBIXBESA-N
Standard InCHI:  InChI=1S/C27H44O2/c1-21(2)11-9-12-25(6)23(21,4)14-15-26(7)24(5)13-10-19(18-28)16-22(24,3)20(29)17-27(25,26)8/h10,18,20,29H,9,11-17H2,1-8H3/t20-,22+,23+,24-,25+,26+,27-/m1/s1
SMILES:  O=CC1=CC[C@@]2([C@](C1)(C)[C@H](O)C[C@]1([C@@]2(C)CC[C@@]2([C@]1(C)CCCC2(C)C)C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL487993
PubChem CID:   44558953
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0001757] Colensane and clerodane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5239 Hyrtios erecta Species Thorectidae Eukaryota n.a. Okinawan n.a. PMID[11076554]
NPO5239 Hyrtios erecta Species Thorectidae Eukaryota n.a. red sea n.a. PMID[16180827]
NPO5239 Hyrtios erecta Species Thorectidae Eukaryota n.a. Red Sea n.a. PMID[17190441]
NPO5239 Hyrtios erecta Species Thorectidae Eukaryota n.a. n.a. n.a. PMID[3572416]
NPO5239 Hyrtios erecta Species Thorectidae Eukaryota n.a. n.a. n.a. PMID[8778242]
NPO5239 Hyrtios erecta Species Thorectidae Eukaryota n.a. n.a. n.a. PMID[9461648]
NPO5239 Hyrtios erecta Species Thorectidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 10.0 ug.mL-1 PMID[507727]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474925 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9524 High Similarity NPC206060
0.9213 High Similarity NPC469545
0.9213 High Similarity NPC61369
0.9213 High Similarity NPC5532
0.9059 High Similarity NPC477579
0.9059 High Similarity NPC235341
0.9059 High Similarity NPC95594
0.8989 High Similarity NPC471207
0.8929 High Similarity NPC307258
0.8864 High Similarity NPC85173
0.8864 High Similarity NPC328141
0.8851 High Similarity NPC472802
0.8837 High Similarity NPC158393
0.8824 High Similarity NPC470812
0.8764 High Similarity NPC272746
0.875 High Similarity NPC184663
0.875 High Similarity NPC472973
0.875 High Similarity NPC69627
0.8721 High Similarity NPC133954
0.8681 High Similarity NPC139570
0.8652 High Similarity NPC191684
0.8652 High Similarity NPC183283
0.8636 High Similarity NPC158778
0.8636 High Similarity NPC328539
0.8632 High Similarity NPC95585
0.8632 High Similarity NPC282233
0.8621 High Similarity NPC475862
0.8621 High Similarity NPC74363
0.8621 High Similarity NPC213412
0.8587 High Similarity NPC471039
0.8571 High Similarity NPC23170
0.8571 High Similarity NPC269729
0.8556 High Similarity NPC145067
0.8556 High Similarity NPC472975
0.8556 High Similarity NPC472978
0.8556 High Similarity NPC4036
0.8556 High Similarity NPC233455
0.8556 High Similarity NPC158030
0.8556 High Similarity NPC99380
0.8556 High Similarity NPC65120
0.8539 High Similarity NPC86319
0.8539 High Similarity NPC275740
0.8539 High Similarity NPC472983
0.8523 High Similarity NPC68160
0.8523 High Similarity NPC142415
0.8523 High Similarity NPC18064
0.8523 High Similarity NPC51700
0.8523 High Similarity NPC130577
0.8523 High Similarity NPC98442
0.8523 High Similarity NPC73064
0.8523 High Similarity NPC242468
0.8523 High Similarity NPC171203
0.8523 High Similarity NPC293564
0.8523 High Similarity NPC307426
0.8523 High Similarity NPC88716
0.8523 High Similarity NPC102683
0.8506 High Similarity NPC470574
0.8488 Intermediate Similarity NPC64600
0.8478 Intermediate Similarity NPC274417
0.8471 Intermediate Similarity NPC119229
0.8471 Intermediate Similarity NPC473217
0.8462 Intermediate Similarity NPC298554
0.8462 Intermediate Similarity NPC295643
0.8462 Intermediate Similarity NPC214756
0.8462 Intermediate Similarity NPC272075
0.8444 Intermediate Similarity NPC126993
0.8434 Intermediate Similarity NPC470428
0.8427 Intermediate Similarity NPC143767
0.8427 Intermediate Similarity NPC52169
0.8427 Intermediate Similarity NPC470629
0.8427 Intermediate Similarity NPC290690
0.8427 Intermediate Similarity NPC182797
0.8427 Intermediate Similarity NPC474512
0.8427 Intermediate Similarity NPC131470
0.8427 Intermediate Similarity NPC473229
0.8427 Intermediate Similarity NPC473242
0.8427 Intermediate Similarity NPC246708
0.8427 Intermediate Similarity NPC181225
0.8427 Intermediate Similarity NPC17733
0.8427 Intermediate Similarity NPC40552
0.8409 Intermediate Similarity NPC98236
0.8409 Intermediate Similarity NPC34190
0.8409 Intermediate Similarity NPC94755
0.8409 Intermediate Similarity NPC72638
0.8409 Intermediate Similarity NPC269396
0.8404 Intermediate Similarity NPC471966
0.8404 Intermediate Similarity NPC194196
0.8391 Intermediate Similarity NPC180834
0.8391 Intermediate Similarity NPC227132
0.8387 Intermediate Similarity NPC192428
0.8387 Intermediate Similarity NPC473158
0.8372 Intermediate Similarity NPC470813
0.8372 Intermediate Similarity NPC48362
0.837 Intermediate Similarity NPC472976
0.837 Intermediate Similarity NPC472977
0.837 Intermediate Similarity NPC474529
0.837 Intermediate Similarity NPC209868
0.837 Intermediate Similarity NPC222047
0.837 Intermediate Similarity NPC471040
0.8353 Intermediate Similarity NPC2482
0.8352 Intermediate Similarity NPC230064
0.8352 Intermediate Similarity NPC185936
0.8352 Intermediate Similarity NPC168027
0.8333 Intermediate Similarity NPC198664
0.8333 Intermediate Similarity NPC127689
0.8333 Intermediate Similarity NPC130520
0.8333 Intermediate Similarity NPC121798
0.8333 Intermediate Similarity NPC263393
0.8333 Intermediate Similarity NPC119416
0.8333 Intermediate Similarity NPC476949
0.8333 Intermediate Similarity NPC253561
0.8333 Intermediate Similarity NPC61543
0.8333 Intermediate Similarity NPC59263
0.8333 Intermediate Similarity NPC225585
0.8333 Intermediate Similarity NPC161751
0.8333 Intermediate Similarity NPC470588
0.8333 Intermediate Similarity NPC25906
0.8333 Intermediate Similarity NPC474972
0.8333 Intermediate Similarity NPC95246
0.8333 Intermediate Similarity NPC143232
0.8333 Intermediate Similarity NPC234346
0.8333 Intermediate Similarity NPC293048
0.8333 Intermediate Similarity NPC64872
0.8333 Intermediate Similarity NPC270768
0.8333 Intermediate Similarity NPC290972
0.8333 Intermediate Similarity NPC274330
0.8333 Intermediate Similarity NPC80088
0.8315 Intermediate Similarity NPC93778
0.8315 Intermediate Similarity NPC89747
0.8315 Intermediate Similarity NPC475740
0.8315 Intermediate Similarity NPC71507
0.8298 Intermediate Similarity NPC473456
0.828 Intermediate Similarity NPC148523
0.828 Intermediate Similarity NPC473170
0.828 Intermediate Similarity NPC473240
0.8261 Intermediate Similarity NPC69454
0.8256 Intermediate Similarity NPC3915
0.8242 Intermediate Similarity NPC86372
0.8242 Intermediate Similarity NPC130278
0.8242 Intermediate Similarity NPC470589
0.8242 Intermediate Similarity NPC210037
0.8242 Intermediate Similarity NPC126369
0.8242 Intermediate Similarity NPC172361
0.8242 Intermediate Similarity NPC290614
0.8242 Intermediate Similarity NPC111110
0.8242 Intermediate Similarity NPC291028
0.8242 Intermediate Similarity NPC18872
0.8242 Intermediate Similarity NPC227467
0.8242 Intermediate Similarity NPC477872
0.8242 Intermediate Similarity NPC120968
0.8242 Intermediate Similarity NPC7260
0.8242 Intermediate Similarity NPC273621
0.8235 Intermediate Similarity NPC470429
0.8222 Intermediate Similarity NPC471722
0.8222 Intermediate Similarity NPC472739
0.8222 Intermediate Similarity NPC230387
0.8222 Intermediate Similarity NPC474677
0.8214 Intermediate Similarity NPC197659
0.8202 Intermediate Similarity NPC471737
0.8202 Intermediate Similarity NPC474778
0.8202 Intermediate Similarity NPC474733
0.8202 Intermediate Similarity NPC474732
0.8202 Intermediate Similarity NPC472986
0.8202 Intermediate Similarity NPC31564
0.8202 Intermediate Similarity NPC472985
0.8202 Intermediate Similarity NPC145879
0.8202 Intermediate Similarity NPC73038
0.8202 Intermediate Similarity NPC72133
0.8202 Intermediate Similarity NPC325594
0.8191 Intermediate Similarity NPC476327
0.8191 Intermediate Similarity NPC476318
0.8191 Intermediate Similarity NPC167193
0.8191 Intermediate Similarity NPC98874
0.8191 Intermediate Similarity NPC472806
0.8182 Intermediate Similarity NPC74595
0.8182 Intermediate Similarity NPC214043
0.8182 Intermediate Similarity NPC85774
0.8182 Intermediate Similarity NPC264665
0.8182 Intermediate Similarity NPC171789
0.8182 Intermediate Similarity NPC251170
0.8182 Intermediate Similarity NPC146683
0.8182 Intermediate Similarity NPC476412
0.8172 Intermediate Similarity NPC103527
0.8172 Intermediate Similarity NPC74751
0.8161 Intermediate Similarity NPC163236
0.8161 Intermediate Similarity NPC310989
0.8152 Intermediate Similarity NPC300351
0.8152 Intermediate Similarity NPC282616
0.8152 Intermediate Similarity NPC25299
0.8152 Intermediate Similarity NPC306541
0.8152 Intermediate Similarity NPC84319
0.8152 Intermediate Similarity NPC228784
0.8152 Intermediate Similarity NPC301244
0.8152 Intermediate Similarity NPC52021
0.8152 Intermediate Similarity NPC235884
0.8152 Intermediate Similarity NPC155120
0.8152 Intermediate Similarity NPC474525
0.8152 Intermediate Similarity NPC63748
0.8152 Intermediate Similarity NPC288833
0.8152 Intermediate Similarity NPC71074

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474925 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8764 High Similarity NPD6079 Approved
0.875 High Similarity NPD5328 Approved
0.8556 High Similarity NPD7515 Phase 2
0.8409 Intermediate Similarity NPD3618 Phase 1
0.8387 Intermediate Similarity NPD4697 Phase 3
0.8191 Intermediate Similarity NPD5221 Approved
0.8191 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.8191 Intermediate Similarity NPD5222 Approved
0.8172 Intermediate Similarity NPD7748 Approved
0.8105 Intermediate Similarity NPD5173 Approved
0.7978 Intermediate Similarity NPD3666 Approved
0.7978 Intermediate Similarity NPD4786 Approved
0.7978 Intermediate Similarity NPD3133 Approved
0.7978 Intermediate Similarity NPD3665 Phase 1
0.7955 Intermediate Similarity NPD3667 Approved
0.7938 Intermediate Similarity NPD4696 Approved
0.7938 Intermediate Similarity NPD5286 Approved
0.7938 Intermediate Similarity NPD5285 Approved
0.7917 Intermediate Similarity NPD4755 Approved
0.7917 Intermediate Similarity NPD7902 Approved
0.7872 Intermediate Similarity NPD4202 Approved
0.7857 Intermediate Similarity NPD5223 Approved
0.7816 Intermediate Similarity NPD7645 Phase 2
0.7778 Intermediate Similarity NPD5224 Approved
0.7778 Intermediate Similarity NPD5211 Phase 2
0.7778 Intermediate Similarity NPD5225 Approved
0.7778 Intermediate Similarity NPD5226 Approved
0.7778 Intermediate Similarity NPD4633 Approved
0.7755 Intermediate Similarity NPD4700 Approved
0.7717 Intermediate Similarity NPD3573 Approved
0.77 Intermediate Similarity NPD5175 Approved
0.77 Intermediate Similarity NPD5174 Approved
0.7692 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD5141 Approved
0.7604 Intermediate Similarity NPD7900 Approved
0.7604 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7573 Intermediate Similarity NPD6881 Approved
0.7573 Intermediate Similarity NPD6899 Approved
0.7549 Intermediate Similarity NPD5739 Approved
0.7549 Intermediate Similarity NPD6675 Approved
0.7549 Intermediate Similarity NPD6402 Approved
0.7549 Intermediate Similarity NPD7128 Approved
0.7528 Intermediate Similarity NPD4695 Discontinued
0.7525 Intermediate Similarity NPD4754 Approved
0.7476 Intermediate Similarity NPD5697 Approved
0.7447 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD7290 Approved
0.7429 Intermediate Similarity NPD7102 Approved
0.7429 Intermediate Similarity NPD6883 Approved
0.7419 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD5279 Phase 3
0.7404 Intermediate Similarity NPD4730 Approved
0.7404 Intermediate Similarity NPD6011 Approved
0.7404 Intermediate Similarity NPD5168 Approved
0.7404 Intermediate Similarity NPD4729 Approved
0.7404 Intermediate Similarity NPD5128 Approved
0.7404 Intermediate Similarity NPD7320 Approved
0.7379 Intermediate Similarity NPD4768 Approved
0.7379 Intermediate Similarity NPD4767 Approved
0.7368 Intermediate Similarity NPD4753 Phase 2
0.7363 Intermediate Similarity NPD4221 Approved
0.7363 Intermediate Similarity NPD4223 Phase 3
0.7358 Intermediate Similarity NPD8130 Phase 1
0.7358 Intermediate Similarity NPD6617 Approved
0.7358 Intermediate Similarity NPD6869 Approved
0.7358 Intermediate Similarity NPD6650 Approved
0.7358 Intermediate Similarity NPD6649 Approved
0.7358 Intermediate Similarity NPD6847 Approved
0.7333 Intermediate Similarity NPD6373 Approved
0.7333 Intermediate Similarity NPD6014 Approved
0.7333 Intermediate Similarity NPD6013 Approved
0.7333 Intermediate Similarity NPD7525 Registered
0.7333 Intermediate Similarity NPD6012 Approved
0.7333 Intermediate Similarity NPD6372 Approved
0.7312 Intermediate Similarity NPD5329 Approved
0.7308 Intermediate Similarity NPD5701 Approved
0.73 Intermediate Similarity NPD7638 Approved
0.729 Intermediate Similarity NPD8297 Approved
0.729 Intermediate Similarity NPD6882 Approved
0.7283 Intermediate Similarity NPD4788 Approved
0.7264 Intermediate Similarity NPD5250 Approved
0.7264 Intermediate Similarity NPD5248 Approved
0.7264 Intermediate Similarity NPD5169 Approved
0.7264 Intermediate Similarity NPD5247 Approved
0.7264 Intermediate Similarity NPD5249 Phase 3
0.7264 Intermediate Similarity NPD5251 Approved
0.7264 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7264 Intermediate Similarity NPD5135 Approved
0.7264 Intermediate Similarity NPD4634 Approved
0.7234 Intermediate Similarity NPD5330 Approved
0.7234 Intermediate Similarity NPD7146 Approved
0.7234 Intermediate Similarity NPD7521 Approved
0.7234 Intermediate Similarity NPD7334 Approved
0.7234 Intermediate Similarity NPD6409 Approved
0.7234 Intermediate Similarity NPD6684 Approved
0.7228 Intermediate Similarity NPD7640 Approved
0.7228 Intermediate Similarity NPD7639 Approved
0.7204 Intermediate Similarity NPD3668 Phase 3
0.7204 Intermediate Similarity NPD4197 Approved
0.7196 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7196 Intermediate Similarity NPD5216 Approved
0.7196 Intermediate Similarity NPD5217 Approved
0.7196 Intermediate Similarity NPD5127 Approved
0.7196 Intermediate Similarity NPD5215 Approved
0.7188 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD4629 Approved
0.7172 Intermediate Similarity NPD5210 Approved
0.7159 Intermediate Similarity NPD7339 Approved
0.7159 Intermediate Similarity NPD6942 Approved
0.7143 Intermediate Similarity NPD6399 Phase 3
0.7111 Intermediate Similarity NPD3617 Approved
0.71 Intermediate Similarity NPD7614 Phase 1
0.7091 Intermediate Similarity NPD6868 Approved
0.7083 Intermediate Similarity NPD6903 Approved
0.7079 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7064 Intermediate Similarity NPD4632 Approved
0.7053 Intermediate Similarity NPD4689 Approved
0.7053 Intermediate Similarity NPD5690 Phase 2
0.7053 Intermediate Similarity NPD4690 Approved
0.7053 Intermediate Similarity NPD5205 Approved
0.7053 Intermediate Similarity NPD4623 Approved
0.7053 Intermediate Similarity NPD4519 Discontinued
0.7053 Intermediate Similarity NPD4688 Approved
0.7053 Intermediate Similarity NPD4138 Approved
0.7053 Intermediate Similarity NPD4693 Phase 3
0.7041 Intermediate Similarity NPD8034 Phase 2
0.7041 Intermediate Similarity NPD8035 Phase 2
0.7041 Intermediate Similarity NPD6411 Approved
0.703 Intermediate Similarity NPD6084 Phase 2
0.703 Intermediate Similarity NPD6083 Phase 2
0.7024 Intermediate Similarity NPD7331 Phase 2
0.7 Intermediate Similarity NPD5167 Approved
0.6966 Remote Similarity NPD3703 Phase 2
0.6964 Remote Similarity NPD6335 Approved
0.6957 Remote Similarity NPD8259 Clinical (unspecified phase)
0.6937 Remote Similarity NPD6274 Approved
0.6907 Remote Similarity NPD5737 Approved
0.6907 Remote Similarity NPD6672 Approved
0.6903 Remote Similarity NPD7100 Approved
0.6903 Remote Similarity NPD7101 Approved
0.6897 Remote Similarity NPD4691 Approved
0.6875 Remote Similarity NPD5280 Approved
0.6875 Remote Similarity NPD6317 Approved
0.6875 Remote Similarity NPD4694 Approved
0.6875 Remote Similarity NPD7115 Discovery
0.6875 Remote Similarity NPD6009 Approved
0.6848 Remote Similarity NPD4195 Approved
0.6842 Remote Similarity NPD6054 Approved
0.6838 Remote Similarity NPD7507 Approved
0.6837 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6837 Remote Similarity NPD6101 Approved
0.6822 Remote Similarity NPD6412 Phase 2
0.6818 Remote Similarity NPD4808 Clinical (unspecified phase)
0.6818 Remote Similarity NPD4809 Clinical (unspecified phase)
0.6814 Remote Similarity NPD6313 Approved
0.6814 Remote Similarity NPD6314 Approved
0.681 Remote Similarity NPD8328 Phase 3
0.6796 Remote Similarity NPD5290 Discontinued
0.6782 Remote Similarity NPD3700 Clinical (unspecified phase)
0.6782 Remote Similarity NPD4137 Phase 3
0.6782 Remote Similarity NPD3699 Clinical (unspecified phase)
0.6771 Remote Similarity NPD1696 Phase 3
0.6765 Remote Similarity NPD7732 Phase 3
0.6729 Remote Similarity NPD6008 Approved
0.6724 Remote Similarity NPD6370 Approved
0.6723 Remote Similarity NPD7736 Approved
0.6706 Remote Similarity NPD7341 Phase 2
0.6705 Remote Similarity NPD4747 Approved
0.6703 Remote Similarity NPD6117 Approved
0.6696 Remote Similarity NPD6319 Approved
0.6696 Remote Similarity NPD6059 Approved
0.6667 Remote Similarity NPD5695 Phase 3
0.6667 Remote Similarity NPD7604 Phase 2
0.6667 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7319 Approved
0.6667 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4058 Approved
0.6638 Remote Similarity NPD5983 Phase 2
0.6638 Remote Similarity NPD6908 Approved
0.6638 Remote Similarity NPD6015 Approved
0.6638 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6638 Remote Similarity NPD6016 Approved
0.6638 Remote Similarity NPD6909 Approved
0.6635 Remote Similarity NPD4225 Approved
0.6635 Remote Similarity NPD5696 Approved
0.6632 Remote Similarity NPD4752 Clinical (unspecified phase)
0.663 Remote Similarity NPD6116 Phase 1
0.661 Remote Similarity NPD7492 Approved
0.6604 Remote Similarity NPD7632 Discontinued
0.6598 Remote Similarity NPD1694 Approved
0.6581 Remote Similarity NPD5988 Approved
0.6559 Remote Similarity NPD6115 Approved
0.6559 Remote Similarity NPD6697 Approved
0.6559 Remote Similarity NPD6114 Approved
0.6559 Remote Similarity NPD6118 Approved
0.6555 Remote Similarity NPD6336 Discontinued
0.6555 Remote Similarity NPD6616 Approved
0.6535 Remote Similarity NPD5284 Approved
0.6535 Remote Similarity NPD5281 Approved
0.6526 Remote Similarity NPD8028 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data